Status:
TERMINATED
The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
Lead Sponsor:
Integra LifeSciences Corporation
Conditions:
Pilonidal Disease
Eligibility:
All Genders
18+ years
Brief Summary
A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healin...
Detailed Description
This is a prospective case series examining the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pi...
Eligibility Criteria
Inclusion
- Subject has a clinical diagnosis of pilonidal disease.
- Subject is being scheduled for surgical excision of pilonidal disease.
- Subject is at least 18 years of age.
- Subject is willing and able to adhere to protocol requirements and agrees to participate in the study program and comply with the study follow-up regimen.
- Subject is willing to provide written informed consent.
Exclusion
- Subject has a known allergy to porcine-based materials.
- Subject is pregnant
Key Trial Info
Start Date :
March 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 5 2019
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04041037
Start Date
March 26 2019
End Date
November 5 2019
Last Update
April 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AdventHealth Tampa
Tampa, Florida, United States, 33613